European Study of Neonatal Exposure to Excipients (ESNEE)

Excipients affect the safety, efficacy and quality of medicines particularly in neonates who are a highly vulnerable group of patients. At present there is a lack of data about the impact of excipients in this age group, and reports have indicated that some may be toxic for neonates, highlighting the need for an urgent assessment of neonatal excipients. A group of researchers from across Europe (ESNEE) have come together in order to use their combined expertise to address this urgent issue and provide an evidence base for discussion.